Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00195_DB00328_nanopub.RAIz25qUFtIQNcqVZQAk-GTCsEHY4GhsIrN4fd_Ip-D80#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00195_DB00328 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00195_DB00328 label "DDI between Betaxolol and Indomethacin - Nonsteroidal Anti-Inflammatory Agents such as indomethacin may diminish the antihypertensive effect of Beta-Blockers such as betaxolol. Monitor for increases in blood pressure if a nonsteroidal anti-inflammatory agent (NSAID) is initiated/dose increased, or decreases in blood pressure if a NSAID is discontinued/dose decreased; this is particularly important if NSAID treatment is for extended periods of time. Ophthalmic beta-blockers are likely of little concern. [drugbank_resource:DB00195_DB00328]" assertion.
- drugbank_resource:DB00195_DB00328 identifier "drugbank_resource:DB00195_DB00328" assertion.
- drugbank_resource:DB00195_DB00328 title "DDI between Betaxolol and Indomethacin - Nonsteroidal Anti-Inflammatory Agents such as indomethacin may diminish the antihypertensive effect of Beta-Blockers such as betaxolol. Monitor for increases in blood pressure if a nonsteroidal anti-inflammatory agent (NSAID) is initiated/dose increased, or decreases in blood pressure if a NSAID is discontinued/dose decreased; this is particularly important if NSAID treatment is for extended periods of time. Ophthalmic beta-blockers are likely of little concern." assertion.
- drugbank:DB00195 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00195_DB00328 assertion.
- drugbank:DB00328 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00195_DB00328 assertion.